OCM
HALO icon

Orion Capital Management’s Halozyme HALO Stock Holding History

Orion Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$337K Buy
4,300
+550
+15% +$37.5K 0.1% 110
2026
Q1 		$242K Sell
3,750
-100
-3% -$7.05K 0.08% 130
2025
Q4 		$259K Hold
3,850
– – 0.09% 131
2025
Q3 		$282K Buy
3,850
+3,650
+1,825% +$242K 0.1% 125
2025
Q2 		$10.4K Hold
200
– – ﹤0.01% 364
2025
Q1 		$12.8K Hold
200
– – 0.01% 342
2024
Q4 		$9.56K Buy
+200
New +$10.3K ﹤0.01% 360

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Orion Capital Management's HALO Position: Q2 2026 in Review

Orion Capital Management increased its Halozyme (HALO) stake by 15% in Q2 2026, buying an estimated $37.5K and bringing the position to 4,300 shares worth $337K. The position accounts for 0.1% of the portfolio, ranked #110.

Orion Capital Management first reported a position in HALO in Q4 2024 and has held it in 7 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Orion Capital Management held 4,300 shares of Halozyme worth $337K as of Q2 2026.
  • Orion Capital Management bought 550 Halozyme shares in Q2 2026, an estimated $37.5K.
  • Halozyme made up 0.1% of Orion Capital Management's portfolio in Q2 2026, its #110 holding.
  • Orion Capital Management first reported a position in Halozyme in Q4 2024 and has held it in 7 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Orion Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.